COLO-RECTAL CANCER
Clinical trials for COLO-RECTAL CANCER explained in plain language.
Never miss a new study
Get alerted when new COLO-RECTAL CANCER trials appear
Sign up with your email to follow new studies for COLO-RECTAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets 'Undruggable' cancer mutations in first human test
Disease control TerminatedThis was an early safety study testing a new oral drug called MRTX0902, both alone and combined with another cancer drug (adagrasib), in people with advanced solid tumors that have specific genetic mutations in the KRAS pathway. The main goals were to find safe doses and see how …
Matched conditions: COLO-RECTAL CANCER
Phase: PHASE1 • Sponsor: Mirati Therapeutics Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Scientists probe Body's defense response when burning away cancer spread
Knowledge-focused TerminatedThis study aimed to understand how the body's immune system reacts when doctors use heat to destroy lung tumors that have spread from colorectal cancer. Researchers measured immune cells and other markers in the blood and tumor tissue before and after the heat treatment procedure…
Matched conditions: COLO-RECTAL CANCER
Phase: NA • Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated Apr 02, 2026 02:12 UTC